MKI67 and neoplasm: Persistent efforts are being conducted to assess the tumor molecular markers like ki-67 (a proliferation marker), p53, estrogen receptors, progesterone receptors, and E-cadherin (E-cad) of EOC by immunohistochemical (IHC) analysis [11, 12].